Alkaloids represent a highly diverse group of compounds that are related only by the occurrence of a nitrogen atom in a heterocyclic ring. Plants are estimated to produce approximately 12,000 different alkaloids, which can be organized into groups according to their carbon skeletal structures. Alkaloid biosynthesis in plants involves many catalytic steps, catalyzed by enzymes that belong to a wide range of protein families. The characterization of novel alkaloid biosynthetic enzymes in terms of structural biochemistry, molecular and cell biology, and biotechnological applications has been the focus of research over the past several years. The application of genomics to the alkaloid field has accelerated the discovery of cDNAs encoding previously elusive biosynthetic enzymes. Other technologies, such as large-scale gene expression analyses and metabolic engineering approaches with transgenic plants, have provided new insights into the regulatory architecture of alkaloid metabolism. 
sons. Unlike most other types of secondary metabolites, the many classes of alkaloids have unique biosynthetic origins. Despite the diversity of metabolic pathways, several technical breakthroughs have recently contributed to impressive advancements in our understanding of alkaloid biosynthesis. Recent applications of genomics-based technologies, such as expressed sequence tag (EST) databases, DNA microarrays, and proteome analysis, have accelerated the discovery of new components and mechanisms involved in the assembly of alkaloids in plants. Our present ability to investigate secondary metabolism from a combined biochemical, molecular, cellular, and physiological perspective has improved our appreciation for the complex biology of alkaloid pathways. In this review, we discuss recent advances in our understanding of the metabolism and trafficking of alkaloids.
Alkaloid Biosynthetic Pathways
Monoterpenoid indole alkaloids. The monoterpenoid indole alkaloids (MIA) comprise a family of structurally and pharmaceutically diverse alkaloids. Some of the approximately 2,000 known compounds widely used in medicine include vinblastine for the treatment of cancer and ajmaline for antiarrythmic heart disorders. The major sources for these compounds are Catharanthus roseus and Rauvolfia serpentina. MIAs are condensation products of a nitrogen-containing indole moiety derived from tryptamine and a monoterpenoid component derived from the iridoid glucoside secologanin (Figure 1 ). In the MIA biosynthetic pathway, tryptophan decarboxylase (TDC) converts tryptophan to tryptamine; the gene encoding this enzyme has been cloned from different MIA-accumulating plants (25, 89, 178) . Incorporation experiments with isotopically labeled glucose in C. roseus cell cultures showed that the initial steps for the biosynthesis of the monoterpenoid skeleton proceed via the triose phosphate/pyruvate pathway (22) . Cognate cDNAs for 1-deoxy-d-xylulose 5-phosphate reductoisomerase and 2C-methyl-d-erythritol 2,4-cyclodiphosphate synthase were isolated from C. roseus and the corresponding gene transcripts were upregulated in MIA-producing cell cultures (163) . The first committed step in secologanin biosynthesis is catalyzed by the cytochrome P450 monooxygenase geraniol-10-hydroxylase (Cyp76B6), which was purified and cloned from C. roseus (20) . Several steps in the secologanin pathway have not been characterized, although the availability of C. roseus EST databases (108) has led to the recent discovery of loganic acid methyltransferase (LAMT) (V. De Luca, personal communication). The final reaction of this early branch of the pathway involves an oxidative C-C cleavage catalyzed by a second P450 monooxgenase (Cyp72A1), resulting in the conversion of loganin to secologanin (70) .
Strictosidine, the common precursor to all MIAs, is formed by a Pictet-Spengler condensation of tryptamine and secologanin (Figure 1 ). Strictosidine synthase (STR) from R. serpentina was the first cDNA involved in alkaloid biosynthesis to be cloned and functionally expressed in microorganisms. STR orthologs from C. roseus and Ophiorrhiza pumila have also been isolated (79, 99, 178) . The strictosidine glucose moiety is subsequently removed by a family 1 glucosyl hydrolase enzyme, strictosidine β-dglucosidase (SGD); a cDNA for SGD was functionally characterized from C. roseus and R. serpentina. SGD from R. serpentina shows exclusive substrate specificity toward strictosidine and closely related analogs (46, 50) . The strictosidine-derived aglycone is subsequently converted via several unstable intermediates to dehydrogeissoschizine, which represents a key branchpoint intermediate that leads to several diverse MIA pathways. The branch pathways proceeding through tabersonine and polyneuridine aldehyde have been characterized most thoroughly. Other branch pathways, such as that leading to catharanthine, remain poorly understood.
Hydroxylation of tabersonine at position 16 represents the first reaction leading to vindoline (Figure 1) . The responsible enzyme, tabersonine 16-hydroxylase (T16H, Cyp71D12), belongs to the P450 monooxygenase family, and the corresponding cDNA was identified from a subset encoding P450-dependent enzymes induced by the treatment of C. roseus cultures with light (140) . O-Methylation at position 16, reduction of the 2,3-double bond, and N-methylation result in the conversion of 16-hydroxytabersonine to desacetoxyvindoline. Although cDNAs have not been isolated for the enzymes that participate in these steps, the N-and O-methylating activities have been characterized in plant extracts (27, 37) . The 2-oxoglutarate-dependent dioxygenase desacetoxyvindoline 4-hydroxylase (D4H) produces desacetylvindoline, which is further converted by the acetyl CoA-dependent desacetylvindoline 4-O-acetyltransferase (DAT) to vindoline (150, 162) . Both enzymes have been cloned and characterized from C. roseus. DAT belongs to the BAHD (benzylalcohol Oacetyl-, anthocyanin-O-hydroxycinnamoyl-, anthranilate-N-hydroxycinnamoyl/benzoyl-, and deacetylvindoline 4-O-acetyltransferase) family of acyl-CoA dependent acyltransferases; these proteins participate in a variety of plant secondary metabolic pathways. Ultimately, vindoline is coupled to catharanthine by a nonspecific peroxidase to form vinblastine (145) . A cDNA with 78% amino acid identity to DAT was obtained from C. roseus and encodes minovincinine 19-O-acetyltransferase, yielding echitovenine, which is a second pathway originating from the tabersonine branch (80) . Whereas minovincinine acetyltransferase (MAT) shows residual activity toward the DAT substrate, deacetoxyvindoline, DAT accepts only its natural substrate.
The polyneuridine aldehyde branch of the MIA pathway is initiated by the formation of a bond, known as the sarpagan bridge, between C5 and C16 of strictosidine-derived intermediate compounds (Figure 1) . The enzyme characterized from crude extracts of R. serpentina shows NADPH and oxygen dependence, and is sensitive to P450 inhibitors, suggesting it is a P450 monooxygenase (139) . The resulting polyneuridine aldehyde undergoes desterification to yield epi-vellosimine, which is acetylated to form vinorine. Recombinant polyneuridine aldehyde esterase (PNAE) from R. serpentina shows esterase activity only to polyneuridine aldehyde and not to structurally related esters, and is a member of the α/β hydrolase superfamily (29) . With approximately 30% identity on the amino acid level to DAT and MAT, vinorine synthase (VS) from R. serpentina also belongs to the BAHD family of acyltransferases (11) . Acetylajmaline is subsequently formed via a series of reactions that includes hydroxylation, two double bond reductions, and an N-methylation. The enzymes involved in these steps have been biochemically characterized as the P450-dependent monooxygenase vinorine hydroxylase (VH), which yields vomilenine, and the NADPH-dependent reductases vomilenine reductase and 1,2-dehydrovomilenine reductase (39, 44, 166) . Acetylajamaline esterase (AAE) ultimately hydrolyzes the 17-O-acetyl group to produce ajmaline. Active recombinant AAE, which could be produced only via a virus expression system in Nicotiana benthamiana, shows slight substrate preference for acetylajmaline compared with norajmaline. The latter compound might represent an intermediate in a parallel ajamaline biosynthetic pathway in which N-methylation occurs after deesterification (134) . Unlike PNAE, AAE belongs to the GDSL lipase family. Raucaffricine, a glucosylated derivative of vomilenine, is found in R. serpentina cultures. Al-
BIA: benzylisoquinoline alkaloid
Sanguinarine: an antimicrobial benzylisoquinoline alkaloid sometimes used in oral hygiene products though the glucosylating activity has not been reported, researchers found a cDNA encoding the enzyme raucaffricine O-β-glucosidase (RG), responsible for deglycosylation of raucaffricine (168) . RG shares 60% amino acid identity with SGD and accepts strictosidine as a substrate, whereas SGD is not active against raucaffricine.
Benzylisoquinoline alkaloids. Benzylisoquinoline alkaloids (BIA) represent approximately 2,500 elucidated structures and possess potent pharmacological properties. The most prominent compounds are the narcotic analgesic morphine, the cough suppressant codeine, the muscle relaxant papaverine, and the antimicrobial agents sanguinarine and berberine. Collectively, these alkaloids occur mainly in the Papaveraceae, Ranunculaceae, Berberidaceae, and Menispermaceae; Papaver somniferum (opium poppy), Eschscholzia californcia, Thalictrum species, and Coptis japonica are the most extensively investigated species. BIA biosynthesis, which fundamentally involves the condensation of two tyrosine derivatives, begins with the decarboxylation of tyrosine to tyramine or of dihydroxyphenylalanine to dopamine by tyrosine decarboxylase (TYDC). TYDC constitutes a large gene family; approximately 15 members are found in opium poppy (33) . Dopamine is the precursor for the isoquinoline moiety, whereas 4-hydroxyphenylacetaldehyde, resulting from the deamination of tyramine, is incorporated as the benzyl component ( Figure 2) . As is the case in MIA biosynthesis, BIA condensation is a Pictet-Spengler-type reaction and is catalyzed by the first committed step of the pathway, norcoclaurine synthase (NCS). The enzyme has been purified from Thalictrum flavum and corresponding cDNAs have been isolated and functionally characterized from opium poppy and T. flavum (87, 136, 137) . NCS is related to the pathogenesis related protein (PR) 10 recombinant T. flavum NCS has been accomplished using a continuous enzyme assay based on circular dichroism spectroscopy that follows the generation of the enzyme's chiral product. These studies revealed a reaction mechanism that involves a twostep cyclization with a direct electrophilic aromatic substitution (91) . Recently, a second enzyme capable of producing only the (S )-norcoclaurine enantiomer was isolated from C. japonica; this enzyme displays sequence similarity to 2-oxoglutarate dependent dioxygenases (102) . However, this enzyme does not possess a 2-oxoglutaratebinding domain and requires ferrous ions, rather than 2-oxoglutarate or oxygen, for activity. Remarkably, two proteins in two different protein families can catalyze the same reaction in vitro. Nevertheless, the relative participation of each enzyme in BIA biosynthesis in vivo must still be determined.
The conversion of (S )-norcoclaurine to (S )-reticuline involves O-methylation at position 6, N-methylation, 3 -hydroxylation, and a second 4 -O-methylation (Figure 2) . Norcoclaurine 6-O-methyltransferase (6OMT) and 3 -hydroxy-N-methylcoclaurine 4 -Omethyltransferase (4 OMT) are both class II O-methyltransferases that display strict regiospecificity. Cognate cDNAs have been obtained for each enzyme from opium poppy and C. japonica (107, 121, 182) . Additional 6OMT homologs from Thalictrum tuberosum were functionally characterized and exhibit a broader substrate specificity that includes catechols and phenylpropanoids in addition to various BIA derivatives (42) . Coclaurine N-methyltransferases (CNMT) have been cloned from opium poppy and C. japonica and are more closely related to S-adenosyl-L-methionine (SAM)-dependent cyclopropane fatty acid synthases than other N-methyltransferases (19, 35) . The hydroxylation of N-methylcoclaurine is catalyzed by a P450 monooxygenase classified in the Cyp subfamily 80B (65, 68, 125, 138) .
(S )-Reticuline is the central pathway intermediate from which most BIA structural types are derived. Only the dimeric bisbenzylisoquinoline alkaloids are not produced via (S )-reticuline. In this pathway, the cytochrome P450 enzyme Cyp80A1 catalyzes the regio-and stereoselective oxidative C-O phenol coupling of the reticuline precursor N-methylcoclaurine to produce the bisbenzylisoquinoline alkaloid berbamunine (78) Biosynthesis of the benzylisoquinoline alkaloids berberine, morphine, and sanguinarine. Enzymes for which corresponding molecular clones have been isolated are shown in bold. Abbreviations: 4 OMT, 3 -hydroxy-N-methylcoclaurine 4 -O-methyltransferase; 6OMT, norcoclaurine 6-O-methyltransferase; 7OMT, reticuline 7-O-methyltransferase; BBE, berberine bridge enzyme; CFS, cheilanthifoline synthase; CNMT, coclaurine N-methyltransferase; CoOMT, columbamine O-methyltransferase; COR, codeinone reductase; Cyp719A1, canadine synthase; Cyp719A2, stylopine synthase; Cyp719B1, salutaridine synthase; Cyp80A1, berbamunine synthase; Cyp80B3, N-methylcoclaurine 3 -hydroxylase; DBOX, dihydrobenzophenanthridine oxidase; DRR, 1,2-dehydroreticuline reductase; DRS, 1,2-dehydroreticuline synthase; MSH, N-methylstylopine 14-hydroxylase; NCS, norcoclaurine synthase; P6H, protopine 6-hydroxylase; SalAT, salutaridinol 7-O-acetyltransferase; SalR, salutaridine:NADPH 7-oxidoreductase; SOMT, scoulerine 9-O-methyltransferase; STOX, (S )-tetrahydroxyprotoberberine oxidase; TNMT, tetrahydroprotoberberine cis-N-methyltransferase; TYDC, tyrosine decarboxylase. from opium poppy (121) . (R,S )-Reticuline 7-O-methyltransferase (7OMT) does not accept N-demethylated BIA substrates, but is active toward phenolic compounds.
A major branch pathway that gives rise to many BIA classes begins with the formation of (S )-scoulerine by the berberine bridge enzyme (BBE) (Figure 2) . This enzyme has been cloned from several sources (28, 36, 138) and was recently characterized thoroughly (174, 175) . BBE belongs to a novel family of flavoproteins that possess two covalent attachment sites for flavin adenine dinucleotide (FAD); one is histidine and the other is cysteine. The cysteinylation of the cofactor increases the midpoint redox potential to a value higher than that observed for other flavoproteins, thereby facilitating hydride abstraction of (S )-reticuline. This step represents the first half reaction toward the conversion to (S )-scoulerine. The biosynthesis of benzophenanthridine alkaloids is initiated by the formation of two methylenedioxy bridges resulting in (S )-cheilanthifoline and (S )-stylopine ( Figure 2) . Both reactions are catalyzed by P450-dependent monooxygenases and two cDNAs coding for stylopine synthase have been cloned from E. californica and classified as Cyp719A2 and Cyp719A3 (67) . Both recombinant proteins show the same regiospecificity for methylendioxy bridge formation, but Cyp719A2 only converts (S )-cheilanthifoline to (S )-stylopine. In contrast, Cyp719A3 also accepts compounds without a pre-existing methylenedioxy bridge. (S )-Stylopine is subsequently N-methylated to (S )-cis-N-methylstylopine by tetrahydroprotoberberine N-methyltransferase (TNMT). On the basis of homology to CNMT, a cDNA encoding TNMT has been isolated and functionally characterized from opium poppy (86) . The enzyme shows a narrow substrate range in that it converts only tetrahydroprotoberberine alkaloids with dimethoxy or methylenedioxy functional groups at C2/3 and C9/10, respectively. TNMT is also one of only a few plant enzymes able to catalyze the formation of quaternary ammonium compounds. Subsequent hydroxylation by (S )-cis-N-methylstylopine 14-hydroxylase yields protopine, which is further hydroxylated by protopine 6-hydroxylase to dihydrosanguinarine. Both enzymes have been detected in protopine alkaloid-containing cell cultures, and their characterization suggests that they are P450 monooxygenases (132, 156) . Dihydrobenzophenanthridine oxidase, which converts dihydrosanguinarine to sanguinarine, has been purified from Sanguianaria canadensis (7) .
An alternative branch for the metabolism of (S )-scoulerine in some species involves the formation of (S )-tetrahydrocolumbamine by scoulerine 9-O-methyltransferase (SOMT) (Figure 2 ) (155) . The cDNA encoding SOMT from C. japonica was the first reported clone for an O-methyltransferase specifically implicated in BIA metabolism.
All O-methyltransferases in the BIA pathway exhibit considerable homology. Tetrahydrocolumbamine is converted to columbamine, which is methylated by columbamine O-methyltransferase (CoOMT) to yield palmatine (106) . Recombinant CoOMT is active only against protoberberine alkaloid substrates, such as scoulerine or tetrahydrocolumbamine, but not against other BIA derivatives. The subsequent formation of a methylenedioxy bridge is catalyzed by canadine synthase, a P450 enzyme that belongs to the Cyp719A family (68) . Cyp719A1 displays high substrate specificity for tetrahydrocolumbamine and does not accept columbamine. As such, a parallel path to berberine via this columbamine is unlikely. (S )-Canadine, or (S )-tetrahydroberberine as it is also called, is oxidized by either (S )-canadine oxidase or (S )-tetrahydroberberine oxidase (STOX), which catalyze the same reaction but show substantially different biochemical properties.
Whereas all pathways downstream of reticuline begin with the (S )-epimer, conversion to the (R )-epimer of reticuline is a required entry step into the morphinan alkaloid biosynthetic pathway (Figure 2 ). The epimerization of reticuline is a two-step process that involves the oxidation of (S )-reticuline by 1,2-dehydroreticuline synthase and the reduction of 1,2-dehydroreticuline to (R )-reticuline. Both steps have been characterized biochemically and the enzymes have been partially purified (23, 63) . Intramolecular carbon-carbon phenol coupling between C2 of the benzyl and C4a of the isochinoline moiety leads to the formation of salutaridine. This enzyme belongs to the P450 monooxygenase family (48) . The gene encoding salutaridine synthase (SalSyn) was recently cloned from opium poppy on the basis of its higher expression in morphine-containing Papaver species and the enzyme was then functionally characterized (A. Gesell, F.C. Huang, J. Ziegler & T.M. Kutchan, manuscript in preparation). The SalSyn protein shows high homology to the methylenedioxybridge-forming P450-dependent enzymes, and was classified as Cyp719B1. The next step in the pathway is catalyzed by salutaridine reductase (SalR); a cognate cDNA was obtained via the same approach used for SalSyn (183) . Functional characterization of the recombinant enzyme showed the stereospecific reduction of the keto group to 7(S )-salutaridinol, which is also reported for the purified enzyme from opium poppy (49) . The enzyme belongs to the family of short chain dehydrogenases/reductases (SDR), but unlike many other enzymes in this family it exhibits a higher molecular weight and is monomeric. The stereospecific reduction of salutaridine is required for the next step, which is catalyzed by salutaridinol 7-O-acetyltransferase (SalAT). This enzyme specifically acetylates the 7(S )-epimer of salutaridinol to salutaridinol-7-O-acetate (82) . With considerable sequence homology to the acetylating enzymes from the MIA pathway, SalAT also belongs to the BAHD family of acetyltransferases (52) . The introduced acetyl group is eliminated spontaneously, leading to the formation of an oxide bridge between C-4 and C-5 to yield thebaine, the first pentacyclic alkaloid of the pathway (82) . The final steps toward the biosynthesis of
SDR: short chain dehydrogenases/ reductases
Calystegines: nortropane alkaloids thought to serve as nutritional sources for soil microorganisms morphine consist of two demethylations and one reduction. Both the demethylation from thebaine to neopinone, which isomerises to codeinone, and from codeine to morphine are not yet understood and no enzymes capable of catalyzing either reaction have been detected. Codeinone reductase has been purified and cloned from opium poppy, and, in contrast to SalR, belongs to the aldo-keto reductase (AKR) family (83, 160) .
Tropane alkaloids and nicotine. Tropane alkaloids are an important class of plantderived anticholinergic compounds, such as hyoscyamine and scopolamine, that occur in several Hyoscyamus, Atropa, and Datura species. Calystegines, which function as selective glucosidase inhibitors, are more widely spread than hyoscyamine and scopolamine in the plant kingdom and occur mainly in the Solanaceae and Convolvulaceae (30) . Nicotine, the active principle in Nicotiana species, acts on nicotinic acetylcholine receptors to cause a variety of physiological effects, including addiction. Tropane alkaloid and nicotine biosynthesis begin with the methylation of putrescine to N-methylputrescine by putrescine N-methyltransferase (PMT) (Figure 3) . The isolation of the cDNA encoding PMT from tobacco was one of the first examples of the successful integration of metabolite and gene expression profiles as a strategy to isolate cDNAs implicated in plant secondary metabolite biosynthesis (61) . Homologous cDNAs from other plants that produce tropane alkaloids, such as Hyoscyamus niger, Atropa belladonna, and Solanum tuberosum, have also been isolated (147, 153, 157) . The second step in the pathway is the oxidative deamination of Nmethylputrescine to 4-methylaminobutanal by N-methylputrescine oxidase (MPO). This enzyme belongs to a class of amine oxidases that require copper as a cofactor. This property was exploited in a homologybased cloning strategy to isolate the MPO cDNA from tobacco (59) . The central intermediate N-methyl-1 -pyrrolium cation for Biosynthesis of the tropane alkaloids hyoscyamine and scopolamine, the calystegines, and nicotine. tropane alkaloid and nicotine biosynthesis results from the spontaneous cyclization of 4-methylaminobutanal. For nicotine, the cation is condensed with nicotinic acid to form 3,6-dihydronicotine, which subsequently undergoes dehydrogenation to nicotine by enzymes that remain poorly characterized.
Nicotine can be N-demethylated to form nornicotine, which is an undesirable derivative owing to its role as the precursor of the carcinogen N -nitrosonornicotine. On the basis of the differential abundance of transcripts corresponding to several P450-encoding cDNAs in tobacco varieties acccumulating nicotine and nornicotine, a clone for nicotine N-demethylase (NND) was identified and classified as Cyp82E4 (144, 176) . Recently, Gavilano & Siminszky (45) described an additional cDNA with NND activity (Cyp82E5v2) that shows distinct tissuespecific expression in tobacco. Although enzymatic activities have not been demonstrated, the condensation of N-methyl-1 -pyrrolium cation with acetoacetic acid is purported to yield hygrine, the precursor of tropane alkaloids (Figure 3) . Hygrine is converted to tropinone, which is subsequently reduced to intermediates that lead to hyoscyamine or calystegines depending on the stereochemistry of the reduction. Tropinone reductase I (TR-I) catalyzes the reduction of tropinone to tropine, which possesses a 3α configuration. In contrast, tropinone reductase II (TR-II) catalyzes the formation of ψ-tropine, which has a 3β configuration. Cognate cDNAs show that both NADPH-dependent enzymes belong to the SDR family and exhibit considerable amino acid sequence similarity (76, 110, 111, 113) . Domain-swapping experiments and sitedirected mutagenesis led to the identification of the substrate-binding domain responsible for the opposite stereospecificity of each reductase. Tropine then condenses with the phenylalanine-derived (R )-phenyllactate to yield littorine, which undergoes rearrangement to form hyoscyamine. Recently, Li and coworkers (84) used functional genomics based on virus-induced gene silencing to isolate a cytochrome P450 involved in littorine rearrangement from H. niger. This enzyme was classified as Cyp80F1 and it catalyzes the oxidation of (R )-littorine with rearrangement to hyoscyamine aldehyde. Finally, the epoxidation of hyoscyamine yields scopolamine via a two-step reaction: 6β-hydroxylation of the tropane ring followed by intramolecular epoxide formation. The reaction is catalyzed by a 2-oxoglutarate-dependent dioxygenase, hyoscyamine 6β-hydroxylase (H6H), the cDNA for which has been cloned from several tropane alkaloid-containing plants (88, 95, 154) . Biosynthesis of the purine alkaloids caffeine and theobromine. Molecular clones have been isolated for all enzymes shown. Abbreviations: CS, caffeine synthase; DXMT, 1,7-dimethylxanthosine methyltransferase; MXMT, 7-methylxanthine methyltransferase; TS, theobromine synthase, XMT, xanthosine 7-Nmethyltanferase.
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Coffea arabica (103, 158) . The second step in the purine alkaloid pathway is the hydrolysis of xanthosine to 7-methylxanthine, although the responsible enzyme has not yet been purified or characterized. However, detailed structural investigations of XMT suggest a coupled reaction for 7-N-methylation and nucleoside cleavage catalyzed by a single enzyme (97) . Several cDNAs with different substrate specificities have been obtained from tea, coffee, or cacao that catalyze the next two N-methylations. Caffeine synthase (CS) performs dual methylations, first at position 3 to form theobromine, and then at position 1 to yield caffeine (74, 104) . Several cDNAs encoding related enzymes that catalyze only single N-methylations have been isolated, including 7-methylxanthine methyltransferase (MXMT1 and MXMT2) and theobromine synthase (TS), which methylate position N-3, and 3,7-dimethylxanthine methyltransferase (DXMT), which catalyzes the final methylation at position N-1 (117, 158) . These N-methyltransferases possess more then 80% amino acid similarity and phylogenetic analysis suggests that they are more closely related to carboxyl-methyltransferases than to other N-methyltransferases.
Pyrrolizidine alkaloids. Pyrrolizidine alkaloids are produced constitutively in various plants as a defense against hebivores and as a component of the complex chemical ecology between plants and animals (55) . These alkaloids are composed of a necine base and one or more necic acids; the latter are responsible for their structural diversity. Necine biosynthesis begins with the condensation of spermidine and putrescine to form homospermidine by homospermidine synthase (HSS) (116) (Figure 5 ). The reaction mechanism is identical to that of deoxyhyposine synthase (DHS), which transfers the aminobutyl moiety to a lysine residue of the eukaryotic initiation factor 5A precursor protein. Additionally, both enzymes share extensive sequence homology, suggesting the recruitment of HSS from DHS, with subsequent optimization to facilitate the role of HSS in secondary metabolism. Phylogenetic analysis of HSS and DHS homologs from angiosperms that represent several unrelated plant lineages suggests at least four independent recruitment events for HSS (128) . The remaining components of pyrrolizidine alkaloid metabolism are not well understood.
Structure-Function Relationships in Alkaloid Biosynthetic Enzymes
The biomimetic exploitation of enzymes, especially those that display strict stereospecificity, is an appealing strategy for the commercial production of pharmaceutical alkaloids. Equally intriguing is the synthesis of novel alkaloids via protein engineering aimed at altering the substrate specificity of biosynthetic enzymes. Recent attention has focused on elucidating the reaction and substrate binding mechanisms of key alkaloid biosynthetic enzymes. The structures of several enzymes have been determined and substrate-binding pockets have been characterized. The first detailed structures of enzymes involved in plant alkaloid metabolism were obtained by X-ray crystallography for TR-I and TR-II, which show strict product specificities and catalyze either tropine or ψ-tropine formation. Site-directed mutagenesis of selected amino acids in the substrate-binding domains resulted in a mutual conversion of the product specificities for TR-I and TR-II (114) . A homology-based model of the threedimensional structure of PMT was generated on the basis of the crystal structure of the putative ancestral enzyme spermidine synthase, which suggested the identity of amino acids responsible for the distinction between these two enzymes (157) .
Most X-ray crystallographic data have been obtained for enzymes implicated in MIA metabolism, especially those involved in Homology-based model: an atomic-resolution protein structure based on amino acid sequence Substrate docking: a mathematical procedure used to identify ligandbinding sites in proteins ajmaline biosynthesis. The structure of STR from R. serpentina revealed a novel six-bladed β-propeller protein and site-directed mutagenesis showed the importance of a key glutamate residue in catalysis (93) . The structure of the enzyme complexed with the natural substrates tryptamine and secologanine provided insight into the architecture of the substrate binding sites, which could then be engineered to accommodate several different tryptamine and secologanin analogs (18, 90) . The threedimensional structure of SGD revealed the expected (β/α) 8 barrel fold typical for family 1 glycosidases (9). Site-directed mutagenesis identified amino acid residues required for the catalytic mechanism and the binding site architecture. Ruppert and coworkers (133) reported preliminary X-ray crystallographic data for the homologous enzyme RG. A comparision of the structures of SGD and RG will be interesting because both enzymes occur in the same organism and catalyze the same type of reaction, but differ in substrate specificity. VS was the first BAHD acyltransferase family enzyme for which a three-dimensional structure was obtained (92) . The protein consists of two major domains of similar size connected by a large loop. Whereas site-directed mutagenesis and structural analysis confirm the importance of a HXXXD motif for catalysis, a second highly conserved motif in members of the BAHD family is distant from the active site and is considered essential for proper folding rather than catalysis. Molecular modeling and site-directed mutagenesis established the classification of PNAE as a member of the α/β hydrolase superfamily and identified the amino acid residues that participate in the catalytic triad (96) .
The structure of SalR (involved in BIA biosynthesis) was analyzed by homology modelling (47) . An additional helix near the catalytic site not found in multimeric SDR-type enzymes appears to contribute to substrate specificity. Substrate docking studies and sitedirected mutagenesis revealed several amino acids implicated in the binding of the morphinan alkaloid precursor salutaridine. It will be
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Laticifer: a plant cell or vessel that contains latex interesting to compare the substrate-binding site of SalR with that of COR, which specifically reduces codeinone, an alkaloid with a similar structure, to salutaridine. The potential of homology modelling and substrate docking is well demonstrated in studies involving the O-methyltransferases implicated in BIA metabolism (S. Pienkny, J. Ziegler & W. Brandt, manuscript in preparation). Although highly similar to 6OMT, the modelling and substrate docking results for a novel O-methyltransferase precluded norcoclaurine as a likely substrate, and rather suggested the O-methylation of norreticuline at position 7. Experimental evidence has confirmed this prediction and led to the identification of N7OMT. Furthermore, comparisons of the 6OMT and N7OMT models identified the amino acids responsible for the distinct substrate specificity.
Recently, McCarthy & McCarthy (97) elucidated the structures of the two highly homologous N-methyltransferases involved in caffeine biosynthesis, XMT and DXMT. Cocrystallization with the cofactor and either substrate, coupled with structural comparisons, revealed critical elements for substrate selectivity and catalysis.
REGULATION OF ALKALOID BIOSYNTHETIC PATHWAYS

Transcriptome and Metabolome Analyses
Large-scale expression analyses have recently begun to provide a broad picture of the gene expression profiles associated with alkaloid biosynthesis. As a prerequisite for these studies, several EST sequencing projects have been reported and the number of sequences associated with alkaloid-producing plants continues to increase. The first database consisted of 4,500 ESTs from the laticifers of opium poppy (127) . Further EST projects involving this plant have yielded a total of 25,000 ESTs from various tissues including seedlings, stems, roots, and elicited cell cultures (182, 183, 184) . A recent floral genome project contributed 11,000 ESTs from the BIA-accumulating plant E. californica (17) , and the release of a C. japonica database has also been announced (69, 75) . NapGen, a consortium of Canadian investigators, has sequenced more than 400,000 ESTs from a wide variety of plants that produce health-related secondary compounds. In this project, 46,000 ESTs were sequenced from cell cultures of eight BIA-accumulating species including E. californica, T. flavum, Nandina domestica, and Papaver bracteatum (D.K. Liscombe, J. Ziegler & P.J. Facchini, manuscript in preparation). More than 56,000 ESTs have been obtained from leaf, leaf epidermis, and roots of the MIA-accumulating plant C. roseus (108) . Large-scale sequencing projects for tropane alkaloid-containing plants, such as S. tuberosum, are also well established. Although research in potato is primarily aimed at the discovery of genes involved in fungal resistance, the 62,000 ESTs from aerial and underground organs are a good source to identify cDNAs implicated in calystegine biosynthesis (131) . A sequencing project targeting tropane alkaloid metabolism yielded 2,300 ESTs from roots of H. niger (84) . In a similar effort to investigate the transcriptional regulation associated with the chemical composition of coffee, Lin and coworkers (85) reported 47,000 ESTs from Coffea canephora at different stages of seed development.
Large-scale transcriptome and metabolite profiling has been performed in opium poppy cell cultures treated with a fungal elicitor (184) , and in C. roseus and tobacco cell cultures treated with methyl jasmonate (51, 129) . In all cases, researchers observed a coordinated increase in the expression of genes implicated in alkaloid metabolism. Moreover, profound changes in the level of gene transcripts encoding primary metabolic enzymes also occurred. Interestingly, transcripts involved in SAM recycling increased in all three systems, indicating a high demand for this cofactor in the modification of alkaloid backbone structures. As expected, genes implicated in aromatic amino acid metabolism were also induced in opium poppy and C. roseus in response to the increased demand for the precursors of BIA and MIA biosynthesis (129, 184) . Surprisingly, the expression of genes associated with nitrogen metabolism was not affected in opium poppy cultures, suggesting that the cells have a constitutive and sufficient capacity for nitrogen assimilation even during periods of increased demand (184) . However, substantial changes occurred in the levels of primary metabolites involved in the production of energy molecules potentially required by enzymes and other components required by the induction of alkaloid biosynthesis (184) . In C. roseus, the construction of correlation networks that integrate transcriptomic and metabolomics data revealed a correlation between the expression of alkaloid biosynthetic genes and corresponding metabolic products (129) .
Gene Regulation and Signal Transduction
Progress has continued on the identification of promoter elements and transcription factors involved in the regulation of several MIA biosynthetic genes (165) . The recent application of a genomics approach based on DNA macroarrays constructed from ESTs has led to the isolation of the first transcription factor putatively involved in the regulation of BIA metabolism. Transcripts that encode a subset of transcriptional regulators showed coordinate expression with respect to BIA biosynthetic genes in berberine-producing C. japonica cell cultures. One of these regulators, a WRKY transcription factor, was shown by RNAi and overexpression analysis to specifically regulate the expression of BIA biosynthetic genes (75) . With respect to early signal transduction events, considerable effort has been focused on events associated with the induction of alkaloid metabolism in E. californica cell cultures, which accumulate benzophenanthridine alkaloids such as sanguinarine in response to treatment with a fungal elicitor. Two different signal transduction pathways were identified. One cascade is jasmonatedependent and responds to high elicitor concentrations. The other is jasmonateindependent and is triggered by low elicitor concentrations (38) . The jasmonateindependent pathway involves Gα proteins that interact and activate phospholipase A2, which leads to a transient proton efflux from the vacuole and a subsequent activation of other cytoplasmic components (60, 164) .
Transgenic Approaches
The application of transgenic technologies to alkaloid-producing plants is primarily intended to increase the synthetic capacity of desired product via the overexpression of certain genes, or to divert pathways to previously under-represented or novel compounds through posttranscriptional gene silencing. However, such experiments also provide insights into the regulatory architecture of alkaloid pathways, especially if the predicted outcome is not observed. Unexpected metabolic consequences resulting from single-enzyme perturbations of alkaloid pathways suggest the existence of key rate-limiting steps, potential multienzyme complexes, or unsuspected compartmentalization.
Metabolic engineering of low-scopolamine A. belladonna plants via the introduction of a constitutively expressed H6H transgene led to an increase in scopolamine accumulation (179) . Similarly, a shift in the accumulation of hyoscyamine in favor of scopolamine occurred when the H6H transgene was introduced into A. beatica, suggesting that the enzyme is a rate-limiting step in scopolamine biosynthesis (180) . However, the unpredictability of metabolic engineering in tropane alkaloid biosynthesis was demonstrated by the constitutive coexpression of PMT and H6H. The transgenes caused only modest increases in alkaloid accumulation when expressed alone, but exhibited a synergistic effect on alkaloid levels when expressed together (181) .
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Latex: the milky cytoplasm of specialized cells called laticifers
In MIA biosynthesis, the first attempts at metabolic engineering focused on the expression of constitutive TDC and STR transgenes in C. roseus cell cultures (31) . However, only unsustained increases in alkaloid accumulation were reported, which raises concerns about the actual relationship between the transgenes and the initial phenotype (16) . Overexpression of enzymes responsible for production of the indole moiety, such as anthranilate synthase (AS), resulted in higher levels of tryptophan, but not alkaloids (64, 66) . Monoterpenoid pathway reactions have long been considered the rate-limiting steps in MIA production. In this context, overexpression of a modified 3-hydroxy-3-methylglutaryl-CoA reductase leads to a predictable increase in alkaloid content (8) . The role of secologanin biosynthesis in the control of flux into MIA metabolism is underscored by the ectopic overexpression of transcriptional regulators of the pathway. T-DNA activation tagging in C. roseus cell cultures resulted in the isolation of an octadecanoid-derivative responsive Catharanthus AP2-domain protein (ORCA3), which activates the expression of genes encoding AS, TDC, STR, D4H, cytochrome P450 reductase, and D-1-deoxyxylulose 5-phosphate synthase, but not those encoding geraniol 10-hydroxylase, SGD, and DAT (161) . However, alkaloid accumulation in cells transformed with a constitutively expressed ORCA3 transgene occurred only in the presence of exogenous loganin. The combined overexpression of transcriptional activators, such as ORCA2 and ORCA3, and the silencing of repressors, such as the G-box binding factors 1 and 2 and the zinc finger protein family, might be required to activate the entire pathway (100, 126, 143, 161) .
Most of the transgenic work involving BIA metabolism has focused on the modulation of BBE activity. Overexpression of this enzyme in E. californica root cultures results in an increased accumulation of downstream alkaloids and decreased levels of certain amino acids (124) . Conversely, antisense suppression of BBE expression leads to undetectable levels of downstream metabolites and increased cellular pools of amino acids, revealing the impact of perturbations in alkaloid metabolism on primary metabolism (123) . Interestingly, antisense suppression of BBE does not result in the accumulation of its substrate (S )-reticuline or any other upstream alkaloid, suggesting the occurrence of metabolic channels that are abolished in the absence of BBE. In contrast, RNAi lines targeting BBE in E. californica cell cultures result in high (S )-reticuline content (43) . Furthermore, laudanine is detected, implying that the pathway is redirected toward the O-methylation of reticuline by 7OMT. Transgenic opium poppy plants expressing an antisense-BBE construct show increased flux into the morphinan and tetrahydrobenzylisoquinoline branch pathways (40) . Surprisingly, the BBE reaction product (S )-scoulerine also accumulates in the latex of these transgenic plants, although the roots show no alterations in metabolite profile. Whether these results are due to an additional role of BBE in BIA metabolism remains unproven. Opium poppy plants transformed with constitutively expressed or antisense-suppressed Cyp80B3, which encodes N-methylcoclaurine 3 -hydroxylase, also show substantial modulations in alkaloid content (41) . However, as expected the alkaloid profile is not altered because Cyp80B3 acts early in the pathway. Overexpression of COR1, the penultimate step in morphine biosynthesis, also results in opium poppy plants with increased alkaloid content (81) . This increase is attributable to higher levels of morphine, codeine, and-for unexplained reasons-thebaine, which is upstream of COR1 in the pathway. The overexpression of one alkaloid biosynthetic gene might possibly cause the coordinate transcriptional induction of other pathway genes. It would be interesting to subject these transgenic plants to microarray analysis to potentially correlate alterations in transcript abundance with changes in alkaloid profile. In RNAi-silenced COR1 plants, the expression of other known genes from the pathway is unaffected (4). However, the plants accumulate the far upstream intermediate (S )-reticuline rather than codeinone, the substrate of COR. Whether this is based on a feedback mechanism that inhibits the entire morphinan branch pathway or the impairment of a required metabolic channel due to the absence of COR is not known. The presence of multienzyme complexes in morphine biosynthesis is supported by experiments that involve the suppression of SalAT. RNAi-silenced SalAT plants show an accumulation of salutaridine, which is normally not abundant in opium poppy plants (3) . This is surprising because salutaridinol, which does not accumulate, is the substrate for SalAT (Figure 2) . Salutaridine might be channelled to thebaine through an enzyme complex that includes SalR and SalAT.
Experiments involving the overexpression of two O-methyltransferases from the early BIA pathway in E. californica cells suggested a rate-limiting role for 6OMT (69) . Constitutive overexpression of 6OMT led to increased alkaloid content. In contrast, overexpression of 4 OMT had little effect. The E. californica cell culture used in this study appeared to lack a functional 6OMT, which might explain the strong effect of overexpressing a 6OMT transgene. Subsequent biochemical characterization of 4 OMT from E. californica revealed low 6OMT activity, suggesting a role for 4 OMT as a surrogate for 6OMT to facilitate BIA biosynthesis.
Transgenic approaches to alter caffeine biosynthesis have recently focused on the generation of C. arabica plants with reduced caffeine content for the production of decaffeinated coffee. Suppression of MXMT, the second N-methyltransferase in the pathway, results in the reduction of theobromine and caffeine by 50% to 70% in C. arabica and C. canephora (118, 119) . However, MXMT, XMT, and DXMT transcripts are all reduced owing to the high homology between the three genes. An alternative biotechnological strategy has targeted the production of caffeine in non-caffeine-producing plants Idioblast: an individual cell that differs greatly from its neighbors to increase pest resistance. Overexpression of all three N-methyltransferases in transgenic Nicotiana tabacum leads to a substantial (5 ug g −1 fresh weight) accumulation of caffeine in leaves (77, 159) . This is sufficient to reduce by 50% pest damage caused by feeding of the tobacco cutworm Spodoptera litura.
ALKALOID TRAFFICKING
The cell biology of alkaloid metabolism in plants has recently emerged as an exciting field of research. Although the biosynthetic pathways leading to various alkaloid types are of polyphyletic origin, some intriguing paradigms are apparent, including the involvement of multiple cell types for alkaloid biosynthesis and/or accumulation, the targeting of different pathway enzymes to multiple subcellular compartments, and the possibility that multienzyme complexes are ubiquitous. Such complex organization implicates extensive intra-and intercellular transport of pathway intermediates, products, and biosynthetic enzymes.
Cell Type-Specific Localization of Alkaloid Biosynthetic Enzymes
Alkaloids generally accumulate in specific cell types owing to their cytotoxicity and probable role in plant defense responses. For example, alkaloids are sequestered to isolated idioblasts and laticifers in C. roseus (151) , root endodermis and stem cortex/pith in T. flavum (138) , and laticifers in opium poppy (13) . The cellular localization of alkaloid pathways is remarkably diverse and complex. Work on the cellular and developmental complexities and organization of alkaloid biosynthesis in C. roseus and opium poppy, in particular, have established new paradigms in the cell biology of secondary metabolism.
PMT and H6H, which catalyze the first and last steps, respectively, in the biosynthesis of the tropane alkaloid scopolamine, localize to the pericycle in the roots of A. belladonna and Hyoscyamus muticus (56, 153, 154) (Figure 6a first step in nicotine biosynthesis and localizes to the endodermis, outer cortex, and xylem in Nicotiana sylvestris (141, 142) . In contrast, TR-I, an intermediate enzyme in the production of hyoscyamine and scopolamine, resides in the endodermis and nearby cortical cells (112) ; thus, tropane alkaloid intermediates must also traffic between cell types (Figure 7) . The specific pathway intermediates that undergo intercellular translocation are not known. Interestingly, TR-II, which provides pseudotropine for the formation of calystegines, localizes to companion cells of sieve elements in the phloem of potato (73) . Enzymes involved in MIA biosynthesis localize to several different C. roseus organs and cell types. TDC and STR are abundant in roots (151) , but also occur in photosynthetic organs, whereas T16H (149), D4H (162) , and DAT (150) are restricted to young leaves and other shoot organs where vindoline biosynthesis occurs. In situ hybridization and immunocytochemical localization studies have shown that Cyp72A1, TDC, and STR localize to the epidermis of stems, leaves, and flower buds (70, 151) (Figure 6b) . In roots, these enzymes occur in cells near the apical meristem. In contrast, D4H and DAT are associated with laticifers and idioblasts of shoots, but are absent from roots. Laticifers and idioblasts are distributed throughout the mesophyll in leaves, often several cell layers away from the epidermis; thus, vindoline biosynthesis involves at least two distinct cell types and requires the intercellular translocation of pathway intermediates. Moreover, gene transcripts that encode enzymes involved in the MEP pathway, along with geraniol 10-hydroxylase, colocalize to the internal phloem parenchyma of young C. roseus aerial organs (15, 120) . These results suggest the translocation of vindoline biosynthetic intermediates from the internal phloem to the epidermis and from the epidermis to laticifers and idioblasts (Figure 8) . As is the case in tropane alkaloid metabolism, the specific pathway intermediates that undergo intercellular translocation in MIA biosynthe- and epidermis in the supply of terpenoid precursors to alkaloid biosynthesis requires further evaluation. Pyrrolizidine alkaloids also share a common metabolic pathway in restricted yet diverse taxa (54) . In Senecio species, pyrrolizidine alkaloids are produced in actively growing roots as senecionine N-oxides, which are transported via the phloem to above-ground organs (54) . Senecionine N-oxides are subsequently modified by one or two speciesspecific reactions (i.e., hydroxylation, dehydrogenation, epoxidation, or O-acetylation) that result in the unique pyrrolizidine alkaloid profile of different plants. Inflorescences are the major sites of pyrrolizidine alkaloid accumulation in Senecio jacobaea and Senecio vernalis; jacobine occurs in flowers. HSS is the first committed enzyme in pyrrolizidine alkaloid biosynthesis and localizes to the root endodermis and cortex adjacent to the phloem in S. vernalis (Figure 6c) , which might reflect a functional accommodation for systemic transport of pyrrolizidine alkaloids to the stem (105) . However, HSS is found throughout the root cortex in Eupatorium cannabinum (Figure 6d ) , which like S. vernalis is a member of the Asteraceae (6). In contrast to the general monophyletic origin of BIA biosynthesis (87) , pyrrolizidine alkaloid pathways have evolved in at least four different angiosperm lineages (128) . The differential localization of a key enzyme was interpreted to support the polyphyletic origin for pyrrolizidine alkaloid biosynthesis (6) . In contrast, the monophyletic origin of BIA biosynthesis (87) and the differential localization of gene transcripts in T. flavum and opium poppy suggest the migration of pathway intermediates between cell types.
In opium poppy, BIA accumulation occurs in the articulated laticifers found adjacent or proximal to sieve elements of the phloem (32) . The cytoplasm of laticifers-or latex-contains a full complement of cellular organelles and many large vesicles to which alkaloids are sequestered. Although laticifers were long considered to be the site of BIA biosynthesis and accumulation, the cellular localization of BIA biosynthetic enzymes and gene transcripts has shown that alkaloid synthesis involves other cell types (13, 34, 170) . Initial in situ hybridization experiments demonstrated the localization of TYDC gene transcripts to the phloem, but not to laticifers (34) . The morphinan pathway enzymes salutaridine synthase (Cyp719B1) and salutaridine:NADPH 7-oxidoreductase (SalR) are also not detected in isolated latex (48, 49) . Seven other biosynthetic enzymes-6OMT, CNMT, (S )-N-methylcoclaurine 3 -hydroxylase (Cyp80B3), 4 OMT, BBE, SalAT, and COR-localize to sieve elements in opium poppy and their corresponding gene transcripts localize to associated companion cells (13, 135) (Figure 6e) . The localization of BIA metabolism components to phloem cells distinct from laticifers predicts the intercellular transport of alkaloid biosynthetic enzymes and pathway intermediates and/or products. The implication of sieve elements also breaks a long-standing paradigm in plant biology (Figure 9) . Previously, sieve elements were not known to support complex metabolism, and were assumed to possess only a limited number of proteins required for cell maintenance and solute transport. Recently, the physiological roles for sieve elements have expanded to include the transport of information macromolecules such as RNA (72) and the biosynthesis of jasmonic acid (57) , ascorbic acid (53), and defense-related compounds (167) . Sieve elements clearly possess a previously unrealized biochemical potential.
T. flavum accumulates BIAs such as the antimicrobial agent berberine. In situ RNA hybridization analysis revealed the cell typespecific expression of BIA biosynthetic genes in roots and rhizomes of T. flavum (138) . In roots, gene transcripts for all nine enzymes localize to the pericycle-the innermost layer of the cortex-and adjacent cortical cells (Figure 6f ). In rhizomes, all biosynthetic gene transcripts are restricted to the protoderm of leaf primordia. The protoderm localization of biosynthetic gene transcripts contrasts with the tissue-specific accumulation of BIAs. In roots, protoberberine alkaloids are restricted to endodermal cells upon the initiation of secondary growth, and are distributed throughout the pith and cortex in rhizomes. Thus, the cell type-specific localization of BIA biosynthesis and accumulation are temporally and spatially separated in T. flavum roots and rhizomes, respectively. Despite the close phylogenetic relationships between corresponding biosynthetic enzymes (87), differ- Putative trafficking of benzylisoquinoline alkaloid biosynthetic enzymes and pathway intermediates and/or products.
ent cell types are involved in the biosynthesis and accumulation of BIAs in opium poppy, T. flavum, and perhaps C. japonica.
Subcellular Compartmentalization of Alkaloid Biosynthetic Enzymes
MIA biosynthetic enzymes are associated with at least three different cell types in C. roseusgeraniol 10-hydroxylase (G10H) is found in internal phloem parenchyma of aerial organs (15) , TDC, secologanin synthase, and STR are localized to the epidermis of aerial organs and the apical meristem of roots (70, 151) , and D4H and DAT are restricted to the laticifers and idioblasts of leaves and stems (151); thus, vindoline pathway intermediates must be translocated between cell types. Enzymes involved in monoterpenoid indole alkaloid biosynthesis in C. roseus also localize to at least five subcellular compartments-TDC, D4H, and DAT are in the cytosol (24) , STR and the peroxidase involved in the coupling of MIA monomers localize to the vacuole (98, 99, 145) , SGD is a soluble enzyme purported to associate with the cytoplasmic face of the endoplasmic reticulum (148), the P450-dependent monooxygenases G10H, secologanin synthase (SLS), and T16H are integral endomembrane proteins (20, 149, 177) , and the N-methyltransferase involved in vindoline biosynthesis localizes to thylakoid membranes (27) . It is unclear whether some enzymes, such as T16H, occur in the epidermis, or in laticifers and idioblasts. The complex compartmentation of the monoterpenoid indole alkaloid pathway suggests extensive subcellular trafficking of pathway intermediates. Several enzymes involved in BIA biosynthesis are associated with a subcellular compartment other than the cytosol. In the sanguinarine branch pathway, density gradient fractionation suggested the localization of BBE and P450 monooxygenases to microsomes with a density slightly higher than that of typical endoplasmic reticulum (ER) (5, 10, 132, 156) . Although BBE is not an integral membrane protein, it is initially targeted to the ER and subsequently sorted to a vacuolar compartment (12) . NCS is also predicted to possess a signal peptide for targeting to the ER (137) , and the final oxidation of alkaloids, such as dihydrosanguinarine, likely occurs in an ER-derived compartment (5). The association of BIA biosynthetic enzymes with endomembranes led to speculation that specialized alkaloid-synthesizing vesicles are present in alkaloid-producing cells (5) . Recently, however, Cyp80B3, BBE, and sanguinarine were found to colocalize with the ER in opium poppy cell cultures (2) . Moreover, the induction of sanguinarine biosynthesis correlates with extensive dilations of the ER and the accumulation of an electron-dense flocculent material within the ER. Because the pH optimum of BBE is ∼8.8 (146), sanguinarine biosynthesis is unlikely to involve the vacuole; thus, alkaloid metabolism could be entirely associated with the ER. Indeed, the vacuole might not even be the site of BIA accumulation in cultured cells, as previously thought. Instead, sanguinarine and related alkaloids could be secreted and bound to cell wall components and reabsorbed, reduced to the less-toxic compound dihydrosanguinarine, and further metabolized (171) .
A unique subcellular compartmentalization of enzymes is also present in quinolizidine alkaloid biosynthesis, which occurs in the mesophyll of some legumes. Lysine decarboxylase and the quinolizidine skeletonforming enzyme have been detected in chloroplasts of Lupinus polyphyllus (172) . 13α-Hydroxymultifluorine/13α-hydroxylupanine O-tigloylase is localized to the mitochondrial matrix rather than to chloroplasts where de novo quinolizidine alkaloid biosynthesis is thought to occur (152) . In contrast, epilupinine O-p-coumaryoltransferase is present in a distinct organelle, but has not been unambiguously localized.
Enzyme Complexes and Metabolic Channels
Many metabolic enzymes are generally assumed to interact physically or be in close proximity with other enzymes that participate in common pathways (173) . Theoretically, the existence of multienzyme complexesalso known as metabolic complexes/channels or metabolons-promote the efficiency of cellular metabolism. The direct transfer of a pathway intermediate from one enzyme to another maintains a high local substrate concentration, which avoids the dilution of intermediates released into the cytoplasm. Enzyme complexes also eliminate competition from other enzymes for the same substrate, increase the stability of intermediates, and minimize the deleterious effects of cytotoxic compounds. Recent investigations of the interactions between pathway enzymes have hinted at the importance of metabolic channels in primary and secondary metabolism. The detection of multienzyme complexes has been purported for flavonoid (1, 14, 58) and polyamine (122) metabolism.
The results from the RNAi-mediated silencing of COR genes suggested the possible existence of a multienzyme complex in BIA (4). Although seven enzymatic steps occur between (S )-reticuline and codeinone-the substrate for COR-only (S )-reticuline accumulates at elevated levels. No intermediates between (S )-reticuline and morphine are detected. Removal of COR was suggested to disrupt a metabolic channel composed of morphinan branch pathway enzymes, resulting in the accumulation of an alkaloid intermediate produced by enzymes that are not part of the same complex. Interestingly, thebaine and oripavine, intermediates upstream of substrates acted upon by COR, accumulate to high levels in some opium poppy cultivars (101); thus, researchers expected an accumulation of morphinan branch pathway intermediates. An alternative interpretation not considered by Allen and coworkers (4) is the suppression of 1,2-dehydroreticuline reductase as a possible side effect of silencing COR. 1,2-Dehydroreticuline reductase is one of two enzymes involved in the epimerization of (S )-reticuline to (R )-reticuline. The potential homology between the two reductases could lead to cosilencing.
PERSPECTIVE
Major progress in the elucidation of alkaloid biosynthetic pathways and their regulation has been obtained by application of large scale genomic tools. However, there are several techniques, whose applications are still more or less exclusively confined to model organisms, that might further our understanding of plant alkaloid biosynthesis. Proteome analysis in alkaloid-accumulating plants has been undertaken (26, 71, 115) , but is still limited by the lack of peptide mass databases for the investigated species, which does not allow protein identification by simple peptide mass fingerprinting. Targeted induced local lesions in genomes (TILLING) as a tool to discover point mutations is also dependent on available sequence information (21) . However, the growing sequence database makes the application of this technique feasible in studying mutations in alkaloid-containing plants. The development of sequencing techniques that can generate large datasets within short times will probably be applied to alkaloid producing plants and will provide the basis for many sequence-based approaches that are now limited to plants with sequenced genomes such as Arabidopsis and rice. Whether genome sequencing projects in alkaloid-containing plants will be feasible remains to be seen, because the genomes of the investigated plants are very large (4.7 Gbp for C. roseus or 7.4 Gbp for opium poppy compared with, for example, 1 Gbp for rice). The predicted function of alkaloid biosynthetic enzymes and other components based on the in vitro characterization of gene products must be confirmed in vivo. However, functional genomics remains problematic for most alkaloid-producing plants owing to general limitations in established genetic transformation technologies. Virusinduced gene silencing is a fast method for the generation of transiently transformed plants and works well in a model organism such as N. benthamiana (130) , and protocols for opium poppy and E. californica have recently been developed (62, 169) . Thus, the impact of suppression of candidate genes on alkaloid biosynthesis can be readily examined before stable transformation is applied. Considering the progress in the investigation of alkaloid metabolism achieved in the last 5 years, a look to the future promises further strong developments in the discovery of regulatory networks that lead to alkaloid accumulation in plants.
SUMMARY POINTS
1. The application of genomics technologies has expedited the discovery of new alkaloid biosynthetic genes that encode enzymes and regulatory proteins with novel functions.
2. Large-scale, integrated transcriptomics and metabolomics analyses are providing initial hints about the regulation of alkaloid pathways.
3. Structural analysis of alkaloid biosynthetic enzymes has enabled targeted modifications of substrate-binding sites for the development of biomimetic alkaloid production.
4. Improved transformation protocols have facilitated the establishment of transgenic plants with tailored alkaloid profiles, providing additional insights into the regulation of pathways.
5. Alkaloid biosynthesis and accumulation are associated with a variety of cell types in different plants, including epidermis, endodermis, pericycle, phloem parenchyma, phloem sieve elements and companion cells, specialized mesophyll, and laticifers. A common paradigm is the involvement of multiple cell types and the implied transport of pathway intermediates and/or products.
6. The subcellular compartmentalization of alkaloid biosynthetic enzymes is as complex as the cell type-specific localization of gene transcripts, enzymes, and metabolites. Although the endoplasmic reticulum is a favored site for alkaloid formation, biosynthetic enzymes have been associated with chloroplast thylakoid membranes, mitochondria, vacuoles, and the cytosol.
FUTURE ISSUES
1. Despite impressive advances facilitated by the application of genomics technologies to the discovery of novel genes that encode alkaloid biosynthetic enzymes, a substantial understanding of the regulatory components of alkaloid pathways has been achieved only for terpenoid indole alkaloid metabolism. Genomics approaches should lead to the identification of regulatory genes involved in benzylisoquinoline alkaloid synthesis and other alkaloid pathways.
2. The impact of posttranslational modification of alkaloid biosynthetic enzymes on product accumulation is a black box. Proteomic approaches might explain why the expression levels of some biosynthetic genes do not correlate with alkaloid profiles.
3. Although the involvement of multiple cell types in the biosynthesis and accumulation of many alkaloids has been established, the identity of the pathway intermediates and/or products that undergo intercellular transport is not known. Moreover, the mechanisms of transport-symplastic involving plasmodesmata, or apoplastic involving specific transporters or channels-are poorly understood.
4. The existence of metabolic channels as a common feature of alkaloid biosynthetic pathways has been widely purported, but only scant evidence is available to support their existence. Establishing the interactions among biosynthetic enzymes and other pathway components will facilitate the rational engineering of alkaloid metabolism in plants and microorganisms.
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